Investor Overview

Stock Price

NASDAQ TCMD (Common Stock) $23.23 + 0.23
May 26, 20174:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.

Investor Presentation

Download Documentation Q1 2017 Investor Presentation

Annual Reports

Download Documentation 2016 Annual Report to Stockholders

Company Overview

Tactile Medical is a leader in treatment options for lymphedema and venous ulcer therapies. Tactile Medical develops advanced home therapy devices to improve health and quality of life for patients with chronic swelling conditions. Headquartered in Minneapolis, Minnesota, we advocate for patient access and serve tens of thousands of patients through a national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff. Our products are proven to improve quality of life, increase clinical efficacy, and reduce overall healthcare costs.

Recent News

Tactile Medical Launches First and Only Pneumatic Compression Device for At-Home Head and Neck Lymphedema Treatment in U.S.

May 17, 2017

More than 75 percent of head and neck cancer patients impacted by lymphedema¹ MINNEAPOLIS, May 17,... 

Read More >

Tactile Systems Technology, Inc. Reports First Quarter 2017 Financial Results; Updates 2017 Outlook

May 8, 2017

Q1 Revenue Increase of 45% Year-over-Year MINNEAPOLIS, May 08, 2017 (GLOBE NEWSWIRE) -- Tactile S... 

Read More >

Upcoming Events

There are currently no events scheduled.
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts Investor Contacts | Financial Tear Sheet Financial Tear Sheet